Income Statement SPM Corporation

Stocks

SPM

VN000000SPM9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 2026-07-23			5-day change	1st Jan Change
10,650.00 ^VND	+4.93%		+32.30%	+5.45%

06-07	SPM Corporation Provides Earnings Guidance for the Year 2026	CI
04-19	SPM Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

9bc.YgKUO90eQmutSNmJkyMft9XqaLPwiMFPZdYGrhicQdE.D2SjT4RqNC_ePZW4200ow72zEMKWu-wdJLJs5milFp8ne_NKhUwrWoAY4Q

Published financial data: SPM CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2023	2024	2025
Revenues	406B	298B	254B
Total Revenues	406B	298B	254B
Cost of Goods Sold, Total	336B	237B	193B
Gross Profit	69.7B	60.67B	60.9B
Selling General & Admin Expenses, Total	39.19B	49.3B	54.59B
Other Operating Expenses, Total	39.19B	49.3B	54.59B
Operating Income	30.51B	11.37B	6.31B
Interest Expense, Total	-11.76B	-7.45B	-6.04B
Interest And Investment Income	225M	2M	7.42M
Net Interest Expenses	-11.54B	-7.44B	-6.04B
Currency Exchange Gains (Loss)	-204M	-185M	-23.04M
Other Non Operating Income (Expenses)	-2.27B	402M	-308M
EBT, Excl. Unusual Items	16.5B	4.14B	-56.87M
Gain (Loss) On Sale Of Assets	-	-	-2.81M
EBT, Incl. Unusual Items	16.5B	4.14B	-59.68M
Income Tax Expense	4.39B	-475M	1.64B
Earnings From Continuing Operations	12.12B	4.62B	-1.7B
Net Income to Company	12.12B	4.62B	-1.7B
Net Income - (IS)	12.12B	4.62B	-1.7B
Net Income to Common Incl Extra Items	12.12B	4.62B	-1.7B
Net Income to Common Excl. Extra Items	12.12B	4.62B	-1.7B
Per Share Items
Net EPS - Basic	879.94	335.38	-123.21
Basic EPS - Continuing Operations	879.94	335.38	-123.21
Basic Weighted Average Shares Outstanding	13.77M	13.77M	13.77M
Net EPS - Diluted	879.94	335	-123.21
Diluted EPS - Continuing Operations	879.94	335	-123.21
Diluted Weighted Average Shares Outstanding	13.77M	13.77M	13.77M
Normalized Basic EPS	749.03	188.05	-2.58
Normalized Diluted EPS	749.03	188.05	-2.58
Dividend Per Share	-	500	-
Payout Ratio	-	148.3	-407.05
Supplemental Items
EBITDA	42.47B	28.02B	28.24B
EBITA	30.51B	11.56B	6.51B
EBIT	30.51B	11.37B	6.31B
Total Revenues (As Reported)	406B	298B	254B
Effective Tax Rate - (Ratio)	26.58	-11.47	-2.74K
Total Current Taxes	4.35B	54.75M	1.14B
Total Deferred Taxes	39.75M	-530M	493M
Normalized Net Income	10.31B	2.59B	-35.54M
Supplemental Operating Expense Items
Advertising Expense	-	-	17.01B
Selling and Marketing Expenses	22.89B	23.15B	19.28B
General and Administrative Expenses	16.31B	26.15B	35.31B

Fiscal Period: December	2023	2024	2025
Assets
Cash And Equivalents	178M	30.07B	2.7B
Short Term Investments	2B	-	-
Total Cash And Short Term Investments	2.18B	30.07B	2.7B
Accounts Receivable, Total	794B	723B	721B
Other Receivables	8.71B	35.09B	17.7B
Total Receivables	803B	758B	739B
Inventory	45.37B	40.52B	51.5B
Prepaid Expenses	249M	289M	283M
Other Current Assets, Total	21.18B	35.69B	2.73B
Total Current Assets	872B	865B	796B
Gross Property Plant And Equipment	345B	346B	358B
Accumulated Depreciation	-199B	-212B	-234B
Net Property Plant And Equipment	146B	134B	125B
Long-term Investments	2.75B	2.75B	2.75B
Other Intangibles, Total	4.54B	4.82B	4.96B
Deferred Tax Assets Long-Term	22.3M	552M	58.95M
Other Long-Term Assets, Total	1.44B	2.57B	2.43B
Total Assets	1,026B	1,009B	931B
Liabilities
Accounts Payable, Total	19.87B	25.86B	28.27B
Accrued Expenses, Total	5.56B	6.03B	4.7B
Short-term Borrowings	161B	143B	72.06B
Current Income Taxes Payable	342M	-	-
Other Current Liabilities	15.34B	12.63B	12.79B
Total Current Liabilities	202B	187B	118B
Other Non Current Liabilities	18B	18B	18B
Total Liabilities	220B	205B	136B
Common Stock, Total	140B	140B	140B
Additional Paid In Capital	211B	211B	211B
Retained Earnings	465B	463B	454B
Treasury Stock	-10.04B	-10.04B	-10.04B
Total Common Equity	806B	804B	795B
Total Equity	806B	804B	795B
Total Liabilities And Equity	1,026B	1,009B	931B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.77M	13.77M	13.77M
ECS Total Common Shares Outstanding	13.77M	13.77M	13.77M
Book Value / Share	58.53K	58.37K	57.75K
Tangible Book Value	801B	799B	790B
Tangible Book Value Per Share	58.21K	58.02K	57.39K
Total Debt	161B	143B	72.06B
Net Debt	159B	112B	69.36B
Account Code - Inventory Valuation	-	6	6
Inventories - Raw Materials, Total	33.28B	30.64B	37.83B
Inventories - Work In Process, Total	3.25B	4.75B	10.14B
Inventories - Finished Goods, Total	10.38B	6.15B	4.06B
Inventories - Others	115M	77.05M	356M
Buildings, Total	88.88B	88.88B	105B
Machinery, Total	189B	236B	246B
Accumulated Allowance for Doubtful Accounts (Supple)	-	36.83B	32.53B

Fiscal Period: December	2023	2024	2025
Net Income	12.12B	4.62B	-1.7B
Depreciation & Amortization - CF	11.96B	16.46B	21.73B
Amortization of Goodwill and Intangible Assets - (CF)	-	190M	197M
Depreciation & Amortization, Total	11.96B	16.65B	21.93B
Amortization of Deferred Charges, Total - (CF)	-	52.19M	104M
(Gain) Loss From Sale Of Asset	-	-409M	2.81M
Other Operating Activities, Total	-6.3B	7.96B	21.88B
Change In Accounts Receivable	10.28B	22.07B	30.22B
Change In Inventories	9.87B	5.41B	-10.76B
Change In Accounts Payable	3.07B	3.29B	186M
Change in Other Net Operating Assets	2.79B	-1.16B	137M
Cash from Operations	43.8B	58.47B	62B
Capital Expenditure	-15.72B	-5.46B	-12.1B
Sale of Property, Plant, and Equipment	-	409M	136M
Investment in Marketable and Equity Securities, Total	745M	2B	-
Cash from Investing	-14.97B	-3.05B	-11.96B
Short Term Debt Issued, Total	390B	236B	157B
Total Debt Issued	390B	236B	157B
Short Term Debt Repaid, Total	-439B	-255B	-228B
Total Debt Repaid	-439B	-255B	-228B
Common Dividends Paid	-	-6.85B	-6.91B
Common & Preferred Stock Dividends Paid	-	-6.85B	-6.91B
Cash from Financing	-48.78B	-25.53B	-77.41B
Foreign Exchange Rate Adjustments	-38.51K	-12.05K	4.5M
Net Change in Cash	-19.95B	29.89B	-27.37B
Supplemental Items
Cash Interest Paid	-	-	6.09B
Cash Income Tax Paid (Refund)	10.76B	2.49B	1.19B
Levered Free Cash Flow	14.11B	52.02B	52.6B
Unlevered Free Cash Flow	21.46B	56.67B	56.38B
Change In Net Working Capital	-6.15B	-38.33B	-42.49B
Net Debt Issued / Repaid	-48.78B	-18.68B	-70.5B

Fiscal Period: December	2023	2024	2025
Profitability
Return on Assets	1.82	0.7	0.41
Return on Total Capital	1.93	0.74	0.44
Return On Equity %	1.51	0.57	-0.21
Return on Common Equity	1.51	0.57	-0.21
Margin Analysis
Gross Profit Margin %	17.16	20.38	23.98
SG&A Margin	9.65	16.56	21.5
EBITDA Margin %	10.46	9.41	11.12
EBITA Margin %	7.51	3.88	2.56
EBIT Margin %	7.51	3.82	2.49
Income From Continuing Operations Margin %	2.98	1.55	-0.67
Net Income Margin %	2.98	1.55	-0.67
Net Avail. For Common Margin %	2.98	1.55	-0.67
Normalized Net Income Margin	2.54	0.87	-0.01
Levered Free Cash Flow Margin	3.47	17.47	20.71
Unlevered Free Cash Flow Margin	5.28	19.03	22.2
Asset Turnover
Asset Turnover	0.39	0.29	0.26
Fixed Assets Turnover	2.82	2.13	1.97
Receivables Turnover (Average Receivables)	0.53	0.39	0.35
Inventory Turnover (Average Inventory)	6.7	5.52	4.2
Short Term Liquidity
Current Ratio	4.31	4.62	6.76
Quick Ratio	3.98	4.21	6.29
Operating Cash Flow to Current Liabilities	0.22	0.31	0.53
Days Sales Outstanding (Average Receivables)	684.4	932.23	1.05K
Days Outstanding Inventory (Average Inventory)	54.46	66.29	86.98
Average Days Payable Outstanding	23.88	36.03	48.43
Cash Conversion Cycle (Average Days)	714.98	962.49	1.09K
Long Term Solvency
Total Debt/Equity	20.01	17.74	9.06
Total Debt / Total Capital	16.67	15.07	8.31
Total Liabilities / Total Assets	21.47	20.33	14.59
EBIT / Interest Expense	2.59	1.53	1.04
EBITDA / Interest Expense	3.61	3.76	4.67
(EBITDA - Capex) / Interest Expense	2.27	3.03	2.67
Total Debt / EBITDA	3.8	5.09	2.55
Net Debt / EBITDA	3.75	4.02	2.46
Total Debt / (EBITDA - Capex)	6.03	6.32	4.46
Net Debt / (EBITDA - Capex)	5.95	4.99	4.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-41.95	-26.68	-14.72
Gross Profit, 1 Yr. Growth %	-15.45	-12.95	0.38
EBITDA, 1 Yr. Growth %	-17.94	-34.03	0.62
EBITA, 1 Yr. Growth %	-27.37	-62.1	-42.76
EBIT, 1 Yr. Growth %	-27.18	-62.73	-44.5
Earnings From Cont. Operations, 1 Yr. Growth %	-50.79	-61.89	-136.74
Net Income, 1 Yr. Growth %	-50.79	-61.89	-136.74
Normalized Net Income, 1 Yr. Growth %	-47.52	-74.89	-101.52
Diluted EPS Before Extra, 1 Yr. Growth %	-50.79	-61.93	-136.78
Accounts Receivable, 1 Yr. Growth %	8.91	-8.94	-2.18
Inventory, 1 Yr. Growth %	-17.55	-10.7	27.11
Net Property, Plant and Equip., 1 Yr. Growth %	3.09	-8.53	-6.55
Total Assets, 1 Yr. Growth %	-3.74	-1.71	-7.72
Tangible Book Value, 1 Yr. Growth %	1.23	-0.32	-1.09
Common Equity, 1 Yr. Growth %	1.19	-0.28	-1.07
Cash From Operations, 1 Yr. Growth %	-3.17	33.49	6.04
Capital Expenditures, 1 Yr. Growth %	-9.99	-65.28	121.69
Levered Free Cash Flow, 1 Yr. Growth %	-216.54	268.64	1.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-531.27	164.07	-0.53
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-24.36	-34.76	-20.92
Gross Profit, 2 Yr. CAGR %	-9.37	-14.21	-6.52
EBITDA, 2 Yr. CAGR %	-4.81	-26.42	-18.45
EBITA, 2 Yr. CAGR %	-11.04	-47.54	-53.81
EBIT, 2 Yr. CAGR %	-11.04	-47.9	-54.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.52	-56.69	-62.58
Net Income, 2 Yr. CAGR %	-22.52	-56.69	-62.58
Normalized Net Income, 2 Yr. CAGR %	-20.65	-63.7	-94.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.53	-56.71	-62.58
Accounts Receivable, 2 Yr. CAGR %	6.83	-0.41	-4.7
Inventory, 2 Yr. CAGR %	-3.87	-14.19	6.54
Net Property, Plant and Equip., 2 Yr. CAGR %	4.4	-2.89	-7.54
Total Assets, 2 Yr. CAGR %	-1.98	-2.73	-4.76
Tangible Book Value, 2 Yr. CAGR %	1.32	0.46	-0.71
Common Equity, 2 Yr. CAGR %	1.29	0.45	-0.68
Cash From Operations, 2 Yr. CAGR %	80.29	13.69	18.98
Capital Expenditures, 2 Yr. CAGR %	30.75	-44.1	-12.27
Levered Free Cash Flow, 2 Yr. CAGR %	276.91	107.27	93.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	62.27	237.47	62.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-12.68	-25.14	-28.67
Gross Profit, 3 Yr. CAGR %	-9.5	-10.58	-9.6
EBITDA, 3 Yr. CAGR %	10.19	-15.76	-18.28
EBITA, 3 Yr. CAGR %	6.58	-33.07	-46.29
EBIT, 3 Yr. CAGR %	6.85	-33.44	-46.79
Earnings From Cont. Operations, 3 Yr. CAGR %	13.96	-38.84	-59
Net Income, 3 Yr. CAGR %	13.96	-38.84	-59
Normalized Net Income, 3 Yr. CAGR %	16.69	-45.93	-87.82
Diluted EPS Before Extra, 3 Yr. CAGR %	13.93	-38.86	-59
Accounts Receivable, 3 Yr. CAGR %	6.47	1.29	-0.36
Inventory, 3 Yr. CAGR %	-5.58	-6.2	-2.19
Net Property, Plant and Equip., 3 Yr. CAGR %	3.13	-0.1	-4.13
Total Assets, 3 Yr. CAGR %	-0.88	-1.89	-4.42
Tangible Book Value, 3 Yr. CAGR %	1.77	0.77	-0.06
Common Equity, 3 Yr. CAGR %	1.74	0.76	-0.06
Cash From Operations, 3 Yr. CAGR %	16.98	63.1	11.08
Capital Expenditures, 3 Yr. CAGR %	-18.13	-15.96	-11.52
Levered Free Cash Flow, 3 Yr. CAGR %	-18.82	274.13	63.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.57	90.87	124.59
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-9.57	-16.08
Gross Profit, 5 Yr. CAGR %	-	-8.56	-8.32
EBITDA, 5 Yr. CAGR %	-	-2.13	-2.31
EBITA, 5 Yr. CAGR %	-	-14.01	-23.72
EBIT, 5 Yr. CAGR %	-	-14.3	-24.07
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-12.66	-27.01
Net Income, 5 Yr. CAGR %	-	-12.66	-27.01
Normalized Net Income, 5 Yr. CAGR %	-	-19.03	-64.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-12.68	-27.02
Accounts Receivable, 5 Yr. CAGR %	-	3.15	1.86
Inventory, 5 Yr. CAGR %	-	18.82	-0.91
Net Property, Plant and Equip., 5 Yr. CAGR %	-	3.76	-1.28
Total Assets, 5 Yr. CAGR %	-	-0.27	-2.45
Tangible Book Value, 5 Yr. CAGR %	-	1.22	0.77
Common Equity, 5 Yr. CAGR %	-	1.2	0.77
Cash From Operations, 5 Yr. CAGR %	-	10.94	17.77
Capital Expenditures, 5 Yr. CAGR %	-	-18.75	-15.84
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	14.8
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	26.73